Jubilant Life Sciences Ltd

Type: Company

Name: Jubilant Life Sciences Ltd (Jubilant Organosys Ltd)

Nationality: India

Fact Sheet: Fact Sheet for Jubilant Organosys Ltd

First reported Jun 17 2013 - Updated Jun 17 2013 - 2 reports

Jubilant Life board appoints an additional director

Source: IRIS (17-JUN-13)Comments | Post CommentJubilant Life Sciences, an integrated pharma and life sciences company, announced that S Sridhar has been appointed as additional director of the company with effect from June 15, 2013.Shares of the company ... [Published MyIris - Jun 17 2013]

Entities: Jubilant Life Sciences Ltd, Appointed, Life Science, Declination

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

HMT, Jubilant Life & Essel Propack witness surge in trading volumes

Source: IRIS (05-JUN-13)Comments | Post CommentBelow is the list of stocks which registered sharp rise in trading volume at the BSE and NSE on Wednesday, Jun 05, 2013:1. HMT observed a rise of 2.19 times in total traded volume over 22-DMA to 681,961 both ... [Published MyIris - Jun 05 2013]

Entities: Essel Propack Ltd, Jubilant Life Sciences Ltd, Witness

First reported May 29 2013 - Updated May 29 2013 - 3 reports

Jubilant Life to split pharma business into two subsidiaries

Jubilant Life Sciences is splitting its pharmaceutical business into two subsidiaries with drug development set to become a separate entity and is exploring options to list the pharma vertical to reduce debt. ... [Published Business Standard India - May 29 2013]

Entities: Jubilant Life Sciences Ltd, Drugs

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Jubilant Lifesciences Orders U.S. Recall Of Acid-Reflux Indian Generic

Home » Blogs » Related Biotechnology, Pharmaceutical and Healthcare NewsJubilant Cadista announced a recall of the delayed-release version of its pantoprazole generic acid-reflux drug from the U.S. market, citing good manufacturing practices violations ... [Published BioPortfolio - May 21 2013]

Entities: Jubilant Life Sciences Ltd, United States, acid-reflux, Biotechnology

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Jubilant Life trades in green despite its arm recalling Pantoprazole Sodium drug from US market

Jubilant Life Sciences is currently trading at Rs 157.00, up by 1.20 points or 0.77% from its previous closing of Rs 155.80 on the BSE.The scrip opened at Rs 156.00 and has touched a high and low of Rs 157.80 and Rs 156.00 respectively. So far 497 shares ... [Published Arihant Capital - May 21 2013]

Entities: Pantoprazole, Jubilant Life Sciences Ltd, Sodium, Drugs

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Gammon Construction Ltd

Reliance Infra, L&T and Jubilant Lifesciences may witness some action today

Reliance Infrastructure is in the process of pulling out of mega projects worth 20,000 crore due to inordinate delays by government agencies in fulfilling commitments relating to these projects. The Anil Ambani-led company hived off its new power projects ... [Published Indian-Commodity - May 21 2013]

Entities: Jubilant Life Sciences Ltd, Moga (India), Gammon Construction Ltd

First reported Mar 19 2013 - Updated Mar 19 2013 - 1 reports

Anthem infuses Rs.100 cr to get into bio-pharma products from its dedicated 2nd unit

Anthem Group has planned an investment of Rs.100 crore to open its second production facility at the Harohalli Industrial Area in Bengaluru. The facility is coming up on a 15 acre area of the Karnataka Industrial Area Development Board (KIADB). The project ... [Published PharmaBiz - Mar 19 2013]

Entities: Infusion, Biology, Chemistry

First reported Feb 27 2013 - Updated Feb 27 2013 - 1 reports

Jubilant Life's Canada facility gets warning letter from US FDA

Jubilant Life Sciences, a Rs.4,250 crore pharma company from Noida, has received warning letter from US Food and Drugs Administration (FDA) for significant violations of current Good Manufacturing Practices (cGMP) regulations at its manufacturing facility, ... [Published PharmaBiz - Feb 27 2013]

Entities: Warning Letter, FDA Food & Drug Administration, Jubilant Life Sciences Ltd

First reported Jan 30 2013 - Updated Jan 30 2013 - 2 reports

Jubilant Life Sciences reports net profit of Rs 26.69 crore

Jubilant Life Sciences has said that its net profit has risen to Rs 26.69 crore during the third quarter of the financial year mainly due to strong sales even as the company faced a foreign exchange loss of Rs 71 crore.The company had recorded a net loss ... [Published Topnews.in - Jan 30 2013]

Entities: Jubilant Life Sciences Ltd, Net Profit, Shyam S Bhartia, Order Book, EBITDA

First reported Jan 30 2013 - Updated Jan 30 2013 - 1 reports

CSR & PHARMA COS

A corporation's first and foremost objective is to maximize returns to its shareholders within the framework of the laws of the countries it operates. In a highly competitive environment of today, corporate houses follow this norm religiously and makes ... [Published PharmaBiz - Jan 30 2013]

Entities: Corporate Social Responsibility, Environment, GlaxoSmithKline Pharmaceuticals Ltd India, Net Profit, Jubilant Life Sciences Ltd

Quotes

"Jubilant Life Sciences Limited (JUBILANT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published

"Jubilant Life Sciences Limited (JUBILANT) - Pharmaceuticals & Healthcare - Deals and Alliances P ... [Published Live-PR.com - May 24 2013]

More From BioPortfolio on "Jubilant Lifesciences Orders U S Recall Of Acid-Reflux Indian Generic"

Jubilant Lifesciences Orders U.S. Recall Of Acid-Reflux Indian Generic [Published BioPortfolio - May 21 2013]

...The US FDA cites the reason of recall as "cGMP deviations, oral products were not manufactured in accordance with good manufacturing practices"

Jubilant arm recalls drug from US market [Published Economic Times - May 21 2013]

Shyam S Bhartia, CMD, and Hari S Bhartia, co-chairman and MD, Jubilant Life Sciences said, "Our strategy of enhancing presence in identified international markets is delivering results with 28% growth and high 73% contribution to revenue mix." He also said that the company can maintain its momentum due to strong product pipeline and order book position...

Jubilant Life Sciences reports net profit of Rs 26.69 crore [Published Topnews.in - Jan 30 2013]

More Content

sort by: Date \| Relevance
Jubilant Life board appoints an additional dire... [Published MyIris - Jun 17 2013]
Jubilant Life appoints S. Sridhar as additional... [Published Moneycontrol.com - Jun 17 2013]
Rupee weak, will gain [Published Financial Chronicle - Jun 16 2013]
Jubilant Life Sciences Limited (JUBILANT) - Fin... [Published Live-PR.com - Jun 13 2013]
HMT, Jubilant Life & Essel Propack witness surg... [Published MyIris - Jun 05 2013]
Indian stock market and companies daily report ... [Published Stock Markets Review - May 30 2013]
Jubilant Life to split pharma business into two... [Published Business Standard India - May 29 2013]
Jubilant Life Sciences to split pharma & drug d... [Published VC Circle - May 29 2013]
Jubilant Life to consolidate pharma segment und... [Published MyIris - May 29 2013]
"Jubilant Life Sciences Limited (JUBILANT) - Ph... [Published Live-PR.com - May 24 2013]
Jubilant Lifesciences Orders U.S. Recall Of Aci... [Published BioPortfolio - May 21 2013]
Jubilant Life trades in green despite its arm r... [Published Arihant Capital - May 21 2013]
Reliance Infra, L&T and Jubilant Lifesciences m... [Published Indian-Commodity - May 21 2013]
Indian stocks to watch-May 21 [Published Yahoo! UK and Ireland - May 21 2013]
Jubilant arm recalls drug from US market [Published Economic Times - May 21 2013]
Jubilant DraxImage Appoints New Member of its E... [Published PR Newswire: Health - Apr 02 2013]
Top 50 pharma cos report 22% growth in sales in... [Published PharmaBiz - Mar 20 2013]
Anthem infuses Rs.100 cr to get into bio-pharma... [Published PharmaBiz - Mar 19 2013]
Jubilant Life's Canada facility gets warning le... [Published PharmaBiz - Feb 27 2013]
Brazil's ANVISA issues water purification norms... [Published PharmaBiz - Feb 23 2013]
Jubilant Life Sciences reports net profit of Rs... [Published Topnews.in - Jan 30 2013]
Jubilant Life Science's net profit at Rs.26.69 ... [Published PharmaBiz - Jan 30 2013]
CSR & PHARMA COS [Published PharmaBiz - Jan 30 2013]
Indian pharma majors have to spend Rs.325 cr un... [Published PharmaBiz - Jan 16 2013]
BSE Healthcare Index closes high at 8132.35 wit... [Published PharmaBiz - Jan 02 2013]
Pharma Outsourcing Services Commanded the Highe... [Published PRWeb - Dec 18 2012]
R&D spending of 30 pharma companies surge by19.... [Published PharmaBiz - Nov 12 2012]
Jubilant Life net jumps to Rs.152 cr in Q2 [Published PharmaBiz - Nov 07 2012]
Governor of Washington State visits Jubilant Li... [Published PharmaBiz - Oct 06 2012]
BSE Healthcare index outperform BSE Sensex in f... [Published PharmaBiz - Sep 29 2012]